Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for STAA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.366M
March 31, 2026 2.147M
December 31, 2025 -19.42M
September 30, 2025 5.283M
June 30, 2025 25.12M
March 31, 2025 35.35M
December 31, 2024 -19.50M
September 30, 2024 -35.24M
June 30, 2024 -20.67M
March 31, 2024 16.19M
December 31, 2023 22.40M
September 30, 2023 31.84M
June 30, 2023 10.17M
March 31, 2023 9.933M
December 31, 2022 -46.72M
September 30, 2022 -101.85M
June 30, 2022 -5.271M
March 31, 2022 -2.539M
December 31, 2021 -4.689M
September 30, 2021 -3.273M
June 30, 2021 -3.524M
March 31, 2021 -2.159M
December 31, 2020 -2.145M
September 30, 2020 -2.049M
June 30, 2020 -2.025M
Date Value
March 31, 2020 -2.185M
December 31, 2019 -2.979M
September 30, 2019 -2.568M
June 30, 2019 -2.398M
March 31, 2019 -2.233M
December 31, 2018 -0.524M
September 30, 2018 -0.452M
June 30, 2018 -0.304M
March 31, 2018 -0.965M
December 31, 2017 -0.077M
September 30, 2017 -0.345M
June 30, 2017 -0.311M
March 31, 2017 -0.313M
December 31, 2016 -0.561M
September 30, 2016 -0.67M
June 30, 2016 -0.968M
March 31, 2016 -1.006M
December 31, 2015 -0.762M
September 30, 2015 -0.582M
June 30, 2015 -0.373M
March 31, 2015 -0.326M
December 31, 2014 -1.605M
September 30, 2014 -0.248M
June 30, 2014 -0.787M
March 31, 2014 -1.414M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. -26.60M
Enovis Corp. -45.01M
Stryker Corp. -639.00M
Zimmer Biomet Holdings, Inc. -190.80M
Edwards Lifesciences Corp. -193.20M